CAS RN: 887603-94-3
ST101
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250714
1mg / 5mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 887603-94-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
887603-94-3 / spiro[1,3-dihydroindene-2,3'-imidazo[1,2-a]pyridine]-2'-one
Standard CAS: 887603-94-3
Multi CAS: No
Basic Information
copy
CAS
887603-94-3 copy
Multi CAS
No copy
Molecular Formula
C15H12N2O copy
Molecular Weight
236.270000 copy
Exact Mass
236.094963 copy
InChI
InChI=1S/C15H12N2O/c18-14-15(17-8-4-3-7-13(17)16-14)9-11-5-1-2-6-12(11)10-15/h1-8H,9-10H2 copy
InChIKey
QZWYXEBIQWJXAR-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
18 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.2 copy
H-bond acceptors
2 copy
Molar refractivity
69.14 copy
TPSA
32.67 copy
LogP / Solubility
WLOGP
1.85 copy
MLOGP
1.63 copy
XLogP3
1.9 copy
Consensus LogP
1.79 copy
Log S (ESOL)
-2.72 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.83 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.73 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.85 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy